Azacitidine 5Azacytidine

5-Azacytidine and the closely related investigational drug decitabine (2'-dexoy-5-azacytidine) have antileukemic activity and induce differentiation. 5-Azacytidine is approved for treatment of myelodysplasia; it induces normalization of bone marrow in 15-20% of patients and reduces transfusion requirement in one-third of patients. It becomes incorporated into RNA and DNA and inhibits methylation of DNA, inducing the expression of silenced genes. Thus, it also is used to induce fetal hemoglobin (HbF) synthesis in sickle cell anemia, although it has been largely replaced for this indication by hydroxyurea. It undergoes very rapid deamination by cytidine deaminase, the product hydrolyzing to inactive metabolites. Its major toxicities include myelosuppression, and rather severe nausea and vomiting when given intravenously in large doses (150-200 mg/m2/day for 5 days). In low-dose daily subcutaneous regimens for myelodysplasia, 30 mg/m2/day, it is well tolerated.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment